C48.1 Malignant neoplasm of specified parts of peritoneum

Name of the Condition

• Malignant neoplasm of specified parts of peritoneum
• Also known as: Peritoneal cancer (specified site), Peritoneal malignancy (localized)

Summary

Malignant neoplasm of specified parts of the peritoneum refers to cancer that originates in distinct regions of the peritoneum, the membrane lining the abdominal cavity and covering abdominal organs. This condition can be primary (arising directly in the peritoneum) or secondary (spreading from other sites). It is a rare form of cancer that may involve specific areas such as the omentum, mesentery, or other localized peritoneal structures.

Causes

The exact causes are not fully understood, but malignant neoplasms in these areas often result from genetic mutations leading to uncontrolled cell growth. Secondary cancers may develop due to metastasis from primary tumors in organs such as the ovary, colon, or stomach. Environmental factors and inherited genetic predispositions may also contribute to risk.

Risk Factors

• Advanced age
• History of other cancers (e.g., ovarian, colorectal, or gastric)
• Exposure to certain carcinogens (e.g., asbestos, industrial chemicals)
• Genetic syndromes (e.g., BRCA mutations)
• Chronic inflammation or infection in the abdominal region

Symptoms

• Abdominal pain or discomfort
• Unexplained weight loss
• Abdominal swelling or bloating
• Changes in bowel habits
• Nausea or vomiting
• Fatigue

Diagnosis

Diagnosis involves a combination of imaging studies (e.g., CT, MRI, or ultrasound) to identify abnormal peritoneal growths, followed by biopsy for histological confirmation. Blood tests may include tumor markers (e.g., CA-125) to support diagnosis, though results are not definitive. Clinical evaluation and correlation with patient history are essential.

Treatment Options

Treatment depends on the cancer's extent, type, and patient health. Options may include surgery to remove tumors, chemotherapy (systemic or intraperitoneal), targeted therapy, or radiation. Multimodal approaches are common, with palliative care considered for advanced cases.

Prognosis and Follow-Up

Prognosis varies based on cancer type, stage, and treatment response. Early detection and localized disease improve outcomes. Follow-up typically includes regular imaging, clinical exams, and monitoring for recurrence. Long-term surveillance is recommended due to potential for metastasis.

Complications

• Peritoneal fluid buildup (ascites)
• Bowel obstruction
• Metastasis to other organs
• Malnutrition or weight loss
• Infection or sepsis

Lifestyle & Prevention

• Maintain a healthy weight and balanced diet
• Avoid exposure to known carcinogens (e.g., asbestos)
• Manage chronic abdominal conditions promptly
• Discuss family cancer history with a healthcare provider

When to Seek Professional Help

Seek medical attention for persistent abdominal pain, unexplained weight loss, or changes in bowel habits. Prompt evaluation is critical if symptoms worsen or new symptoms develop, as early intervention may improve outcomes.

Tips for Medical Coders

Document the specific peritoneal site (e.g., omentum, mesentery) when coding. Ensure clinical records specify the location to support code assignment. Differentiate between primary and secondary neoplasms if documented, as this may impact coding accuracy. Verify that the code aligns with the anatomical site reported in the medical record.